Khanna V, Azenkot T, Liu SQ, Gilbert J, et al. Outcomes with molecularly targeted agents as salvage therapy following frontline venetoclax + hypomethylating agent in adults with acute myeloid leukemia: A multicenter retrospective analysis. Leuk Res 2023;131:107331.
PMID: 37263072